vendredi 27 juin 2014

Placebo and Human Genetics

I was listening to a podcast the other day and it was saying that some people are or might be more predisposed to being susceptible to placebos than others - something to do with a variation of a gene related to dopamine release. If this is the case, how would it affect drug trials? Would people highly susceptible to placebos skew a drug trial and make the drug seem less effective?





via JREF Forum http://ift.tt/1pVMZoq

Aucun commentaire:

Enregistrer un commentaire